A case report of COVID-19 evoked cholangitic liver abscess

Article type: Case Report

Keywords: COVID-19, Cholangitic, Choledocholithiasis, Stent

Authors: Omkolsoum Alhaddad, Maha Elsabaawy ⚬, Ahmed Edrees, Essam Elshimy, Dalia Elsabaawy, Tarek Mansour

Affiliations: grid.411775.10000 0004 0621 4712Department Of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebeen El-Kom, 32511 Egypt; grid.411775.10000 0004 0621 4712Department Of Clinical Pharmacy, National Liver Institute, Menoufia University, Shebeen El-Kom, 32511 Egypt; grid.7269.a0000 0004 0621 1570Department Of Internal Medicine, Faculty of medicine, Ain Shams University, Cairo, Egypt

License: © The Author(s) 2022 CC BY 4.0 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Article links: DOI: 10.1186/s43066-021-00169-6  |  PubMed: 35036011  |  PMC: PMC8750645

Relevance: Relevant: mentioned in keywords or abstract

Full text: PDF (1.5 MB)

Background

The emerging COVID-19 disease has been considered this century’s lethal curse [ref. 1]. Since the first strenuous apprehension from the Chinese city Wuhan, lots of data has been evolving concerning the novel coronavirus [ref. 1]. However, the full-blown clinical scenarios, outcomes, and sequelae have not yet unveiled.

COVID 19-related reports have described a post-recovery state of immunosuppression that would boost serious bacterial and fungal infections [ref. 2, ref. 3].

As more than 60% of liver abscesses are of biliary origin, so stones, stents, and biliary anomalies are considered the most conventional predispositions of developing pyogenic liver abscesses [ref. 4].

Case presentation

A 62-year-old lady recently presented to the emergency room of National Liver Institute, Menoufia University, with 3-day history of high fever (41 °C), chills, but neither respiratory symptoms nor alteration of mental status were present. Clinical examination revealed scleral icterus and significant tenderness over the right hypochondrium.

Her history was significant for COVID-19 pneumonia and ICU admission for around 22 days in a nearby hospital 1 month earlier. The patient’s past history was not significant apart from an open cholecystectomy 20 years ago with uneventful postoperative period. The patient is neither diabetic nor hypertensive, and no history of past endoscopic procedures.

Laboratory investigations on presentation showed hyperbilirubinemia, leukocytosis, and pattern of cholestatic hepatitis, but normal COVID-19-related laboratory markers.

Also, immediate point of care ultrasound (POCUS) revealed a right hepatic lobe focal lesion measuring (10×10cm), along with an evident stent inside the common bile duct (CBD) (Fig. 1). A consecutive computerized tomography scan of the abdomen confirmed the right lobe focal lesion as a complex abscess occupying large area (Figs. 2 and 3).

Sonography guided, a 10-french pigtail catheter was inserted percutaneously into the abscess cavity meanwhile, with aspiration of 50 mL of purulent fluid that was sent for culture and sensitivity. The patient was transferred to the ward and parenteral broad-spectrum antibiotics were initiated. Few days later, the culture and sensitivity results gave priority to Escherichia coli, infection with modulation of prescribed antibiotic.

In the following days, the clinical status of the patient did not show any improvement with persistent fever, discharge from the pigtail, and non-change in sonographic measures of the abscess cavity. The antibiotic regimen was changed according to the results of culture and sensitivity from the pigtail discharge.

Further assessment in the following days has confirmed the condition as non-resolving abscess. This non-response to the classic measures of abscess treatment (culture-based antibiotics and percutaneous drainage) added to the sonographic findings and the cholestatic liver derangement had mandated stepping to endoscopic retrograde cholangiography (ERCP).

The CBD was cannulated after strenuous extraction of a long (20 cm) catheter that was largely displaced into the duodenal lumen. Cholangiogram revealed mildly dilated CBD with multiple large stones accompanied by mildly dilated central biliary radicals. Surprisingly, an old stent was hardly seen inside the dilated CBD, with mild dilatation of the intrahepatic biliary channels (Figs. 4, 5, and 6).

Papillotomy and papilloplasty were undertaken followed by stones’ extraction by a balloon extractor. The procedure was ended by inserting 2 plastic stents (10 cm× 10 f), and a flow of thick dark bile was inspected.

Finally, the patient fully recovered, and the pigtail was removed. Follow-up 2 weeks later revealed stable recovery.

Discussion

Choledocholithiasis is still considerably observed after cholecystectomy and stones can be either old or newly formed [ref. 5]. In the present case, the remote history of cholecystectomy signified the stones on the CBD as de novo choledocholithiasis.

During cholecystectomy and in a case of retained CBD stones, the trans-papillary biliary stenting after CBD compression is considered as an attractive option to avoid T-tube–related complications [ref. 6]. Furthermore, it eases clearing the CBD from any calculi during a planned ERCP to retrieve the intraoperatively applied trans-papillary stent [ref. 7]. In the present patient, it is clear that the surgically placed stent had been forgotten for 20 years.

Neglected biliary plastic stents may act as a core of matrix for lithogenesis triggered by partial obstruction and slowing of the bile flow [ref. 8]. In that milieu, the long-retained biliary stent can foster bacterial proliferation and release of the enzyme beta-glucuronidase, and subsequent precipitation of calcium bilirubinate that then aggregated into stones by an anionic glycoprotein [ref. 9].

The initial non-resolution of the abscess despite the pigtail drainage and culture-sensitivity-guided antibiotics then the cholangiographic picture and rapid resolution after adequate biliary drainage, all prove a communication of the abscess with the intrahepatic biliary system.

The mechanism that would explain the post-COVID liver abscess formation in this patient is apparently hard to reach. One speculation could be the immune evasion which perpetually was described as a sequel of SARS-COV2 infection. The virus-mediated immunosuppression enables opportunistic bacteria to colonize vulnerable tissues in the affected patients [ref. 10]. The forgotten stent, the partially obstructed biliary system, the new calculi, and the surrounding liver tissue all were providing such vulnerability to post COVID-19 bacterial infection.

In viral pandemics, bacteremia particularly with Staphylococcus aureus has been long documented and accused of the associated morbidity and mortality [ref. 11]. Severity of the disease and mortality in Spanish flu (1918–1919) and the H1N1 influenza pandemic (2009–2010) are largely attributed to secondary bacteremia [ref. 12]. In the recently published reports, staph aureus bacteremia has been documented in patients infected with SARS-CoV-2 [ref. 13]. Two reports from New York City have documented bacteremia in patients who suffered from COVID-19. Sepulveda et al. reported that 1.6% of COVID-19 patients had bacteremia, with S. aureus accounting for 13% of these bacteremias [ref. 14]. Nori et al. reported that 1.9% of COVID-19 patients can develop bacteremias [ref. 2].

In recent years, biliary tract disease is the most common source of pyogenic liver abscess [ref. 15]. In such a condition, abscesses are usually multiple; however, solitary abscess can occur because of surgical manipulation or indwelling biliary stents [ref. 16].

Thus, another speculation in the presented case is that COVID-19 pneumonia-associated systemic bacteremia along with hematogenous dissemination can be the background pathology behind bacterial cholangitis and abscess formation.

E. coli is the prevalent liver abscesses pathogen and had been incriminated in triggering right lobe solitary abscesses [ref. 17, ref. 18].

COVID-19 had been convicted in many liver derangements starting from just elevated liver enzymes up to acute fulminant liver failure supporting the hepatic injurious nature of the virus [ref. 19, ref. 20]. A condition might be the clue of this case, as the ongoing COVID-19 hepatic injury paved the way to be the bed for E. coli proliferation and invasion in an immunocompromised patient with an overlooked biliary stent.

The presenting case is exceptional for the asymptomatic de novo choledocholithiasis projecting over the 20-year forgotten surgically applied trans-papillary stent. Also, the post-COVID cholangitic abscess was over-heading a quiescent biliary disease.

Conclusion

In this case, the unique sequel of COVID-19 appraises a new aspect for that threatening virus. More importantly, it necessitates careful evaluation of COVID-19 affected patients, and a full eye follow-up after recovery.

References

1. 1.Mackenzie JS, Smith DW (2020) COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t [published online ahead of print, 2020 Mar 17]. Microbiol Aust. MA20013
2. 2.Nori P, Cowman K, Chen V et al (2020) Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge [published online ahead of print, 2020 Jul 24]. Infect Control Hosp Epidemiol.:1–5
3. SH Shi, ZL Zhai, SS Zheng. Pyogenic liver abscess of biliary origin: the existing problems and their strategies. Semin Liver Dis., 2018. [DOI | PubMed]
4. A Mischnik, WV Kern, R Thimme. Pyogenic liver abscess: changes of organisms and consequences for diagnosis and therapy. Dtsch Med Wochenschr., 2017. [DOI | PubMed]
5. P Chowbey, A Sharma, A Goswami. Residual gallbladder stones after cholecystectomy: a literature review. J Min Access Surg, 2015. [DOI]
6. AM Hassan, AQ Mohamed, AM Shawky. Common bile duct exploration with trans-papillary stenting versus T-tube drainage for management of irretrievable common bile duct stones. Al-Azhar Assiut Med J, 2017. [DOI]
7. A Dietrich, F Alvarez, N Resio. Laparoscopic management of common bile duct stones: trans-papillary stenting or external biliary drainage. JSLS., 2014. [DOI]
8. M Odabasi, C Arslan, S Akbulut. Long-term effects of forgotten biliary stents: a case series and literature review. Int J Clin Exp Med., 2014. [PubMed]
9. V Barai, J Hedawoo, S Changole. Forgotten CBD stent (102 months) with stone-stent complex: a case report. Int J Surg Case Rep., 2017. [DOI | PubMed]
10. M Desforges, A Coupanec, PH Dubeau. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?. Viruses, 2019. [DOI]
11. 11.Siddiqui AH, Koirala J. Methicillin resistant Staphylococcus aureus. [Updated 2020 Jul 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482221/.
12. DM Morens, JK Taubenberger, HA Harvey. The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med., 2010. [DOI | PubMed]
13. A Cusumano, C Dupper, M Yesha. Staphylococcus aureus bacteremia in patients infected with COVID-19: a case series, Open Forum. Infectious Diseases, 2020
14. J Sepulveda, F Lars, L Westblade. Green bacteremia and blood culture utilization during COVID-19 surge in New York City. J Clin Microbiol, 2020. [DOI | PubMed]
15. M Sugiyama, Y Atomi. Pyogenic hepatic abscess with biliary communication. Am J Surg., 2002. [DOI | PubMed]
16. S Engler, C Benz, WR Martin. Leberabszesse–Komplikationen nach Prothesen- und Stentokklusionen [Liver abscesses–complications after prosthesis and stent occlusions]. Ultraschall Med., 1997. [DOI | PubMed]
17. SC Chen, CH Yen, KC Lai. Pyogenic liver abscesses with Escherichia coli: etiology, clinical course, outcome, and prognostic factors. Wien Klin Wochenschr., 2005. [DOI | PubMed]
18. JH Yoon, YJ Kim, SI Kim. Prognosis of liver abscess with no identified organism. BMC Infect Dis, 2019. [DOI | PubMed]
19. D Jothimani, R Venugopal, MF Abedin. COVID-19 and the liver. J Hepatol., 2020. [DOI | PubMed]
20. S Melquist, K Estepp, Y Aleksandrovich. COVID-19 presenting as fulminant hepatic failure: a case report. Medicine (Baltimore)., 2020. [DOI | PubMed]